Shufro Rose & Co. LLC Purchases Shares of 8,850 Bath & Body Works, Inc. (NYSE:BBWI)

Shufro Rose & Co. LLC bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 8,850 shares of the company's stock, valued at approximately $343,000.

Other large investors also recently bought and sold shares of the company. SRS Capital Advisors Inc. boosted its position in shares of Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after purchasing an additional 329 shares during the period. UMB Bank n.a. grew its position in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after acquiring an additional 335 shares during the last quarter. Northwest Bank & Trust Co grew its position in shares of Bath & Body Works by 2.9% during the fourth quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company's stock worth $533,000 after acquiring an additional 419 shares during the last quarter. Lindbrook Capital LLC increased its holdings in shares of Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after acquiring an additional 431 shares during the period. Finally, Cornerstone Investment Partners LLC raised its position in Bath & Body Works by 3.8% in the 4th quarter. Cornerstone Investment Partners LLC now owns 12,248 shares of the company's stock valued at $475,000 after purchasing an additional 452 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Trading Down 1.5%

BBWI stock traded down $0.42 during midday trading on Friday, reaching $28.16. The company had a trading volume of 6,154,657 shares, compared to its average volume of 5,000,590. The company has a 50 day moving average of $30.07 and a two-hundred day moving average of $33.96. The company has a market capitalization of $6.00 billion, a P/E ratio of 6.87, a PEG ratio of 0.92 and a beta of 1.87. Bath & Body Works, Inc. has a 1 year low of $24.96 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. The company had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.42 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business's quarterly revenue was up 2.9% on a year-over-year basis. During the same period last year, the business earned $0.38 EPS. On average, sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Shareholders of record on Friday, June 6th will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.84%. The ex-dividend date is Friday, June 6th. Bath & Body Works's dividend payout ratio is 21.33%.

Bath & Body Works announced that its Board of Directors has initiated a share buyback program on Thursday, February 27th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to repurchase up to 6.4% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's management believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of analysts have weighed in on BBWI shares. Telsey Advisory Group reaffirmed an "outperform" rating and set a $38.00 price objective (down from $43.00) on shares of Bath & Body Works in a research report on Thursday. The Goldman Sachs Group decreased their price target on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a report on Friday. Morgan Stanley dropped their price objective on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating on the stock in a research note on Tuesday, May 6th. Cowen restated a "buy" rating on shares of Bath & Body Works in a research note on Thursday, February 27th. Finally, Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the company an "overweight" rating in a report on Thursday, May 15th. Four investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $42.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.